CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
91 hedge funds and large institutions have $62.5M invested in CureVac in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 25 increasing their positions, 25 reducing their positions, and 16 closing their positions.
186% more capital invested
Capital invested by funds: $21.8M → $62.5M (+$40.6M)
56% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 16
10% more funds holding
Funds holding: 83 → 91 (+8)
1.69% more ownership
Funds ownership: 3.51% → 5.2% (+1.7%)
0% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 25
37% less call options, than puts
Call options by funds: $1.83M | Put options by funds: $2.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$7.82M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$4.69M |
| 3 |
WIC
Water Island Capital
New York
|
+$3.8M |
| 4 |
GCL
Glazer Capital LLC
New York
|
+$2.36M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$6.87M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.38M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$853K |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$625K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$376K |
CVAC Hedge Fund Activity: Q2 2025 in Review
91 institutional investors reported a position in CureVac (CVAC) for Q2 2025, worth a combined $62.5M — up 186% from $21.8M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new CVAC positions and 16 closed out — a net gain of 9 holders — while 25 added to existing stakes and 25 trimmed.
The largest buyer was Alpine Associates Management, opening a new position worth an estimated $7.82M. The largest seller was Millennium Management, cutting an estimated $6.87M.
- 91 institutional investors held CureVac (CVAC) as of Q2 2025, up from 83 in Q1 2025.
- Funds reported $62.5M of CureVac stock for Q2 2025, up 186% quarter-over-quarter.
- 25 funds opened new CureVac positions in Q2 2025 and 16 closed out, a net change of +9 holders.
- The largest CureVac buyer in Q2 2025 was Alpine Associates Management, an estimated $7.82M added.
- The largest CureVac seller in Q2 2025 was Millennium Management, an estimated $6.87M sold.
Based on aggregated 13F filings for Q2 2025.